Q

uniQure NV
D

QURE

14.050
USD
-0.19
(-1.33%)
مغلق
حجم التداول
42,292
الربح لكل سهم
-3
العائد الربحي
-
P/E
-3
حجم السوق
750,795,358
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ALNY
    ALNY
    -2.740
    (-1.10%)
    246.360 USD
    B
    BLUE
    0.05000
    (0.60%)
    8.35000 USD
    C
    CRSP
    0.260
    (0.65%)
    40.520 USD
    E
    EDIT
    -0.03000
    (-2.40%)
    1.22000 USD
    GILD
    GILD
    0.150
    (0.16%)
    91.790 USD
    MRK
    MRK
    -2.790
    (-2.77%)
    97.940 USD
    N
    NTLA
    0.09000
    (0.96%)
    9.50000 USD
    S
    SGMO
    -0.00500
    (-0.45%)
    1.10000 USD
    S
    SLDB
    0.00500
    (0.15%)
    3.26000 USD
    V
    VYGR
    0.01000
    (0.20%)
    5.06000 USD
    المزيد
الأخبار
المقالات

العنوان: uniQure NV

القطاع: Healthcare
الصناعة: Biotechnology
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.